Genentech Withdraws Psoriasis Drug Linked to Brain Infections - Bloomberg.com

Genentech Withdraws Psoriasis Drug Linked to Brain Infections - Bloomberg.com: "Genentech Inc. began pulling its psoriasis treatment Raptiva from the U.S. market because of the drug’s link to a rare, fatal brain disorder that has troubled at least four other medicines." [Bloomberg.com]